Who Owns CareDx Stock?
NASDAQ: CDNAHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 104.06%
- Institutions (% of float)
- 107.39%
- Held by insiders
- 3.10%
- Institutional holders
- 329
- Institutions 96.9%
- Insiders 3.1%
- Public and other 0.0%
Who owns CareDx stock?
Institutional investors own about 104.1% of CareDx's shares, spread across 329 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.10% of CDNA.
The largest institutional holders are Blackrock Inc. (9.31%), State Street Corporation (4.77%) and Vanguard Capital Management LLC (4.25%). Together, the top 10 institutions control 42.2% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CDNA positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CDNA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.81M | 9.31% | +6.5% |
| State Street Corporation | 2.47M | 4.77% | -10.6% |
| Vanguard Capital Management LLC | 2.20M | 4.25% | +1.7% |
| Deerfield Management Company, L.P | 2.00M | 3.86% | -8.8% |
| ARK Investment Management, LLC | 1.95M | 3.78% | -12.3% |
| Boston Partners | 1.94M | 3.75% | +2.9% |
| BAMCO Inc. | 1.94M | 3.74% | -41.9% |
| Gagnon Securities, LLC | 1.77M | 3.42% | +0.5% |
| Chevy Chase Trust Holdings, LLC | 1.44M | 2.78% | -4.4% |
| Geode Capital Management, LLC | 1.33M | 2.57% | +5.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CDNA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.55M | 3.01% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.55M | 2.99% |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 1.37M | 2.66% |
| iShares Trust-iShares Russell 2000 ETF | 1.32M | 2.55% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.21M | 2.33% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 588.49K | 1.14% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 560.76K | 1.08% |
| Invesco Exchange-Traded Fund Trust-Invesco Biotechnology & Genome ETF | 502.68K | 0.97% |
| First Eagle Funds-First Eagle Small Cap Opportunity Fund | 485.14K | 0.94% |
| iShares Trust-iShares Russell 2000 Growth ETF | 480.04K | 0.93% |
Frequently asked questions
Who is the largest shareholder of CareDx?
Blackrock Inc. is the largest institutional shareholder of CDNA, owning 9.31% of shares outstanding (4.81M shares) as of its latest 13F filing.
What percentage of CareDx is owned by institutions?
Institutions own about 104.1% of CDNA shares and 107.4% of the public float.
How much of CareDx do insiders own?
Insiders, such as officers and directors, own about 3.10% of CDNA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.